Insta-Char with Sorbitol Drug Interactions
Currently displaying a list of 81 drugs known to interact with Insta-Char with Sorbitol (charcoal / sorbitol).
- 3 major drug interactions
- 77 moderate drug interactions
- 1 minor drug interaction
Medications known to interact with Insta-Char with Sorbitol
Note: Showing generic names only.
A
- acarbose
- acetaminophen
- acetohexamide
- acetylcysteine
- aminophylline
- amitriptyline
- amobarbital
- amoxapine
- aspirin
B
C
D
- dapsone
- demeclocycline
- desipramine
- digitoxin
- digoxin
- divalproex sodium
- doxepin
- doxycycline
- dyphylline
E
F
G
I
L
M
- magnesium salicylate
- mephenytoin
- mephobarbital
- mesoridazine
- methdilazine
- methionine
- methotrexate
- methotrimeprazine
- miglitol
- minocycline
- mycophenolate mofetil
- mycophenolic acid
N
O
P
- pentobarbital
- perphenazine
- phenobarbital
- phenytoin
- prochlorperazine
- promazine
- promethazine
- propiomazine
- propoxyphene
- protriptyline
S
T
- teriflunomide
- tetracycline
- theophylline
- thiethylperazine
- thioridazine
- tolazamide
- tolbutamide
- trifluoperazine
- triflupromazine
- trimeprazine
- trimipramine
V
W
Insta-Char with Sorbitol disease interactions
There are 7 disease interactions with Insta-Char with Sorbitol (charcoal / sorbitol) which include:
- gastrointestinal obstruction
- seizures
- inflammatory bowel disease
- intestinal obstruction disorders
- fluid expansion
- diabetes
- sodium imbalances
More about Insta-Char with Sorbitol (charcoal / sorbitol)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidotes
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.